Imeglimin(EMD-387008) is the first in a new tetrahydrotriazine-containing class of oral antidiabetic agents, the glimins; It has been shown to act on the liver, muscle and pancreatic -cells to uniquely target the key defects of type 2 diabetes.
仅供研究使用。 我们不向患者出售。
| 名称 | Imeglimin |
|---|---|
| Iupac 化学名称 | 1,3,5-Triazine-2,4-diamine,1,6-dihydro-N,N,6-trimethyl-,(+)-(9CI) |
| 同义词 | EMD 387008; EMD387008; EMD-387008 |
| 英文同义词 | EMD 387008; EMD387008; EMD-387008 |
| 分子式 | C6H13N5 |
| 分子量 | 155.2 |
| Smile | C[C@@H]1NC(=N)N=C(N1)N(C)C |
| InChiKey | GFICWFZTBXUVIG-SCSAIBSYSA-N |
| InChi | InChI=1S/C6H13N5/c1-4-8-5(7)10-6(9-4)11(2)3/h4H,1-3H3,(H3,7,8,9,10)/t4-/m1/s1 |
| Cas号 | 775351-65-0 |
| MDL | MFCD19443705 |
| 相关CAS号 |
| 包装 | 价格 | 库存 | 纯度 | 备货期 |
|---|---|---|---|---|
| 大货 | 询价 | 询价 | 询价 |